The dreaming sleep stage: A new neurobiological model of schizophrenia?

Neuroscience

Volumn 140, Issue 4, 2006, Pages 1105-1115

  Gottesmann, C ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

delusions; hallucinations; neurotransmitters; paradoxical sleep

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD FLOW; BRAIN; BRAIN DAMAGE; BRAIN ELECTROPHYSIOLOGY; DREAMING; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; REVIEW; SCHIZOPHRENIA; SLEEP STAGE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DREAMS; HUMANS; MODELS, NEUROLOGICAL; SCHIZOPHRENIA; SLEEP STAGES;

EID: 33745269268     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.082     Document Type: Review

References (107)

1. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
2. Albe-Fessard D., Massion J., Hall R., and Rosenblith W. Modifications au cours de la veille et du sommeil des valeurs moyennes de réponses nerveuses centrales induites par des stimulations somatiques chez le chat libre. C R Acad Sci 258 (1964) 353-356
3. Araneda R., and Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in the association cortex. Neuroscience 40 (1991) 399-412
4. Aston-Jones G., and Bloom F.E. Activity of norepinephrine-containing neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1 (1981) 876-886
5. Aston-Jones G., and Bloom F.E. Norepinephrine-containing locus coeruleus neurons in behaving rat exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1 (1981) 887-900
6. Behrendt R.P., and Young C. Hallucinations in schizophrenia, sensory impairment and brain disease. an unified model. Behav Brain Sci 27 (2005) 771-787
7. Blagrove M., Blakemore S.J., and Thayer B.R.J. The ability to self-tickle following rapid eye movement sleep dreaming. Conscious Cogn (2006) in press.
8. Bouyer J.J., Montaron M.F., and Rougeul A. Fast fronto-parietal rhythms during combined focused attentive behavior and immobility in cat. cortical and thalamic localizations. Electroencephalogr Clin Neurophysiol 51 (1981) 244-252
9. Brake W.G., Flores G., Francis D., Meaney M.J., Srivastava L.K., and Gratton A. Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex. Neuroscience 96 (2000) 687-695
10. 150 PET study. Brain 120 (1997) 1173-1197
11. Braun A.R., Balkin T.J., Wesensten N.J., Gwardry F., Carson R.E., Varga M., Baldwin P., Belenky G., and Herscovitch P. Dissociated pattern of activity in visual cortices and their projections during human rapid eye movement sleep. Science 279 (1998) 91-95
12. Cantero J.L., Atienza M., Madsen J.R., and Stickgold R. Gamma EEG dynamics in neocortex and hippocampus during human wakefulness and sleep. Neuroimage 22 (2004) 1271-1280
13. Chergui K., Suaud-Chagny M.F., and Gonon F. Non-linear relationship between impulse flow. Dopamine release and dopamine elimination in the rat in vivo. Neuroscience 62 (1994) 641-645
14. Collerton D., Perry E., and McKeith I. Why people see things that are not there. A novel perception and attention deficit model for recurrent complex visual hallucinations. Brain Behav Sci 28 (2005) 737-757
15. Dagnino N., Favale E., Loeb C., Manfredi M., and Seitun A. Presynaptic and postsynaptic changes in specific thalamic nuclei during deep sleep. Arch Ital Biol 107 (1969) 668-684
16. Dahlstrom A., and Fuxe K. Evidence for existence of monoamine-containing neurons in the central nervous system. Acta Physiol Scand 62 Suppl 232 (1964) 3-55
17. Demetrescu M., Demetrescu M., and Iosif G. Diffuse regulation of visual thalamo-cortical responsiveness during sleep and wakefulness. Electroencephalogr Clin Neurophysiol 20 (1966) 450-469
18. Descarries L., Watkins K.C., and Lapierre Y. Noradrenergic axon terminals in the cerebral cortex of rats. III. Topometric ultrastructural analysis. Brain Res 133 (1977) 197-222
19. Douglass A.B. Narcolepsy. differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia. CNS Spectr 8 (2003) 120-126
20. Evarts E.V. Temporal patterns of discharge of pyramidal tract neurons during sleep and waking in the monkey. J Neurophysiol 27 (1964) 152-171
21. Ey H. La dissolution du champ de la conscience dans le phénomène sommeil-veille et ses rapports avec la psychopathologie. Press Med 75 (1967) 575-578
22. Favale E., Loeb C., Manfredi M., and Sacco G. Somatic afferent transmission and cortical responsiveness during natural sleep and arousal in the cat. Electroencephalogr Clin Neurophysiol 18 (1965) 354-368
23. Feenstra M.G.P., Botterblom M.H.A., and Mastenbroek B. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period. effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100 (2000) 741-748
24. Foote S.L., Freedman R., and Oliver A.P. Effects of putative neurotransmitters on neuronal activity on monkey auditory cortex. Brain Res 86 (1975) 229-242
25. Foulkes W.D. Dream reports from different stages of sleep. J Abnorm Soc Psychol 65 (1962) 14-25
26. Franken P., Djik D.J., Tobler I., and Borbely A.A. High-frequency components of the rat electrocorticogram are modulated by the vigilance states. Neurosci Lett 167 (1994) 89-92
27. Frederickson R.C.A., Jordan L.M., and Phillis J.W. The action of noradrenaline on cortical neurons. effects of pH. Brain Res 35 (1971) 556-560
28. Freud S. A note upon the "mystic writing-pad." Standard edition Vol. 19 (1925), The Hogart Press, London 227-232
29. Freud S. L'interprétation des rêves, 1900 (1967), P.U.F, Paris
30. Friedman J.I., Adler D.N., and Davis K.L. The role of norepinephrine in the physiopathology of cognitive disorders. potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46 (1999) 1243-1252
31. Fuxe K., Hamberger B., and Hökfelt T. Distribution of noradrenaline nerve terminals in cortical areas if the rat. Brain Res 8 (1968) 125-131
32. Gandolfo G., Arnaud C., and Gottesmann C. Transmission in the ventrobasal complex of rat during the sleep-waking cycle. Brain Res Bull 5 (1980) 921-927
33. Ghelarducci B., Pisa M., and Pompeiano M. Transformation of somatic afferent volleys across the prethalamic and thalamic components of the lemniscal system during the rapid eye movements of sleep. Electroencephalogr Clin Neurophysiol 29 (1970) 348-357
34. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry. Etymology and strategic intentions. Am J Psychiatry 160 (2003) 636-645
35. Gottesman I.I., and Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A 58 (1967) 199-205
36. Gottesman I.I., and Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 122 (1973) 15-36
37. Gottesmann C. Recherche sur la psychophysiologie du sommeil chez le rat (1967), Presses du Palais Royal, Paris 1-156 [still available, discussion and summary in English]
38. Gottesmann C. La psychophysiologie du sommeil. Bull Psychol 24 (1970) 520-528
39. Gottesmann C. Psychophysiologie du sommeil. Ann Psychol 71 (1971) 451-488
40. Gottesmann C. Neurophysiological support of consciousness during waking and sleep. Prog Neurobiol 59 (1999) 469-508
41. Gottesmann C. Hypothesis for the neurophysiology of dreaming. Sleep Res Online 3 (2000) 1-4
42. Gottesmann C. The neurochemistry of waking and sleeping mental activity. The disinhibition-dopamine hypothesis. Psychiatr Clin Neurosci 56 (2002) 345-354
43. Gottesmann C. Brain inhibitory mechanisms involved in basic and higher integrated sleep processes. Brain Res Rev 45 (2004) 230-249
44. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity. a hypothesis for the etiology of schizophrenia. Neuroscience 41 (1991) 1-24
45. Grace A.A. Gating information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31 (2000) 330-341
46. Grobin A.C., and Deutch A.Y. Dopaminergic regulation of extracellular g-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 285 (1998) 350-357
47. Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation. reciprocal discharge by two brainstem neuronal groups. Science 189 (1975) 55-58
48. Hobson J.A., Stickgold R., and Pace-Schott E.F. The neuropsychology of REM sleep dreaming. Neuroreport 9 (1998) R1-R14
49. Iwama K., Kawamoto T., Sakkakura H., and Kasamatsu T. Responsiveness of cat lateral geniculate at pre- and postsynaptic levels during natural sleep. Physiol Behav 1 (1966) 45-53
50. Jackson J.H. Selected writings 2 vol (1932), Hodden and Stoughten, London
51. Jackson M.E., Frost A.S., and Moghaddam B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in nucleus accumbens. J Neurochem 78 (2001) 920-923
52. Jakovljevic M., Sagud M., and Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD. a series of case reports. Acta Psychiatr Scand 107 (2003) 394-396
53. Kelly P.H. Defective inhibition of dream event memory formation. a hypothesized mechanism in the onset and progression of symptoms of schizophrenia. Brain Res Bull 46 (1998) 189-197
54. Kisley M.A., Olincy A., Robbins E., Polk S.D., Adler L.E., Waldo M.C., and Freedman R. Sensory gating impairment associated with schizophrenia persists into REM sleep. Psychophysiology 40 (2003) 29-38
55. Krnjevic K., and Phillis J.W. Actions of certain amines on cerebral cortex neurons. Br J Pharmacol 20 (1963) 471-490
56. Larsen J.P., and Tandberg E. Sleep disorders with Parkinson's disease. epidemiology and management. CNS Drugs 15 (2001) 267-275
57. Lauriat T.L., Dracheva S., Chin B., Schmeidler J., McInnes L.A., and Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 137 (2005) 843-851
58. Léna I., Parrot S., Deschaux O., Muffat S., Sauvinet V., Renaud B., Suaud-Chagny M.F., and Gottesmann C. Variations in the extracellular levels of dopamine, noradrenaline, glutamate and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res 81 (2005) 891-899
59. Linner L., Wiker C., Wadenberg M.L., Schalling M., and Svensson T.H. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockade-induced dopamine release in the medial prefrontal cortex of the rat. Neuropsychpharmacology 27 (2002) 691-698
60. Llinas R., and Ribary U. Coherent 40 Hz oscillation characterizes dream state in humans. Proc Natl Acad Sci U S A 90 (1993) 2078-2081
61. Luciana M., Collins P.F., and Depue R.A. Opposing role for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex 8 (1998) 218-226
62. MacKay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., and Snyder S. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39 (1982) 991-997
63. Maloney K.J., Cape E.G., Gotman J., and Jones B.E. High-frequency-electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience 76 (1997) 541-555
64. Manunta Y., and Edeline J.M. Effects of noradrenaline on frequency tuning of auditory cortex neurons during wakefulness and slow wave sleep. Eur J Neurosci 11 (1999) 2134-2150
65. Maquet P. Functional neuroimaging of normal sleep by positron emission tomography. J Sleep Res 9 (2000) 207-231
66. Maquet P., and Franck G. REM sleep and amygdala. Mol Psychiatry 2 (1997) 195-196
67. Maquet P., Peters J.M., Aerts J., Delfiore G., Degueldre C., Luxen A., and Franck G. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 383 (1996) 163-166
68. Maquet P., Ruby P., Schwartz S., Laurey S., Albouy T., Dang-Vu T., Desseilles M., Boly M., Melchior G., and Peigneux P. Regional organisation of brain activity during paradoxical sleep. Arch Ital Biol 142 (2004) 413-419
69. Marrosu F., Portas C., Mascia M.F., Casu M.A., Fa M., Giagheddu M., Imperato A., and Gessa G.L. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res 671 (1995) 329-332
70. Massimini M., Ferrarelli F., Huber R., Esser S.K., Singh H., and Tononi G. Breakdown of cortical effective connectivity during sleep. Science 309 (2005) 2228-2232
71. McCormick D.A. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 39 (1992) 337-388
72. McGinty D.J., and Harper R.M. Dorsal raphe neurons. depression of firing during sleep in cats. Brain Res 101 (1976) 569-575
73. McGinty D.J., Harper R.M., and Fairbanks M.K. Neuronal unit activity and the control of sleep states. In: Weitzman E.D. (Ed). Advances in sleep research Vol 1 (1974), Spectrum, New York 173-216
74. Meyer-Lindenberg A., Poline J.B., Kohn P.D., Holt J.L., Egan M.F., Weinberger D.R., and Berman K.F. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158 (2001) 1809-1817
75. Miller J.D., Farber J., Gatz P., Roffwarg H., and German D. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res 273 (1983) 133-141
76. Muzur A., Pace-Schott E., and Hobson J.A. The prefrontal cortex in sleep. Trends Cogn Sci 6 (2002) 475-481
77. Nahum L.H. The functions of dream cycles. Connect Med 29 (1965) 701-705
78. Nelson C.N., Hoffer B.J., Chu N.S., and Bloom F.E. Cytochemical and pharmacological studies on polysensory neurons in the primate frontal cortex. Brain Res 62 (1973) 115-133
79. Nielsen T. cognition in REM and NREM sleep. A review and possible reconciliation of two models of sleep mentation. Behav Brain Sci 23 (2000) 851-866
80. Nishino S., Ripley B., Mignot E., Benson K.L., and Zarcone V.P. CSF hypocretin-1 levels in schizophrenics and control. relationship to sleep architecture. Psychiat Res 110 (2002) 1-7
81. Nishino S., Ripley B., Overheem S., Lammers G.L., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
82. Peled A., Geva A.B., Kremen W.S., Blankfeld H.M., Esfandiarfard R., and Nordahl T.E. Functional connectivity and working memory in schizophrenia. an EEG study. Int J Neurosci 106 (2000) 47-61
83. Perez-Garci E., del Rio-Portilla Y., Guevara M.A., Arce C., and Corsi-Cabrera M. Paradoxical sleep is characterized by uncoupled gamma activity between frontal and perceptual cortical regions. Sleep 24 (2001) 118-126
84. Perry E., Walker M., Grace J., and Perry R. Acetylcholine in mind. a neurotransmitter of consciousness?. Trends Neurosci 22 (1999) 273-280
85. Pirot S., Godbout R., Mantz J., Tassin J.P., Glowinski J., and Thierry A.M. Inhibitory effects of ventral tegmental area stimulation on the activity of the prefrontal cortex neurons. evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience 49 (1992) 857-865
86. Pralong E., Magistretti P., and Stoop R. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Prog Neurobiol 67 (2002) 173-202
87. Reader T.A., Ferron A., Descarries L., and Jasper H.H. Modulatory role for biogenic amines in the cerebral cortex. Microiontopheric studies. Brain Res 160 (1979) 219-229
88. Reeves M., Lindholm D.E., Myles P.S., Fletcher H., and Hunt J.O. Adding ketamine to morphine for patient-controlled analgesia after major abdominal surgery. a double-blind, randomized trial. Anesth Analg 93 (2001) 116-120
89. Ribary U., Ionnides A.A., Singh K.D., Hasson R., Bolton J., Lado F., Mogilner A., and Llinas R. Magnetic field tomography of coherent thalamocortical 40 Hz oscillations in humans. Proc Natl Acad Sci U S A 88 (1991) 11037-11041
90. Rossi G.F., Palestini M., Pisano M., and Rosadini G. An experimental study of the cortical reactivity during sleep and wakefulness. Aspects anatomo-fonctionnels de la physiologie du sommeil (1965), CNRS, Paris 509-532
91. Sarter M., and Bruno J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming. differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95 (2000) 933-952
92. Silver H., Barash I., Aharon N., Kaplan A., and Poyurovsky M. Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients. a placebo-controlled study. Int Clin Psychopharmacol 15 (2000) 257-261
93. Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behav Brain Sci 23 (2000) 843-850
94. Steriade M. Ascending control of thalamic and cortical responsiveness. Int Rev Neurobiol 12 (1970) 87-144
95. Steriade M., Timofeev I., and Grenier F. Natural waking and sleep states. A view from inside neocortical neurons. J Neurophysiol 85 (2001) 1969-1985
96. Takeuchi T., Miyasita A., Inugami M., and Yamamoto Y. Intrinsic dreams are not produced without REM sleep mechanisms. evidence through elicitation of sleep onset periods. J Sleep Res 10 (2001) 43-52
97. Takeuchi T., Ogilvie R.D., Ferrelli A.V., Murphy T., Yamamoto Y., and Inugami M. Dreams are not produced without REM sleep mechanisms. Sleep Res Online 2 suppl 1 (1999) 279
98. Timofeev I., Grenier F., and Steriade M. Disfacilitation and active inhibition in the neocortex during the natural sleep-wake cycle. An intracellular study. Proc Natl Acad Sci U S A 98 (2001) 1924-1929
99. Trulson M.E., and Preussler D.W. Dopamine-containing ventral tegmental area neurons in freely moving cats. activity during the sleep-waking cycle and effects of stress. Exp Neurol 83 (1984) 367-377
100. Van Hes R., Smid P., Stroomer C.N., Tipker K., Tulp M.T., Van der Heyden J.A., McCreary A.C., Hesselink M.B., and Kruse C.G. SL V310, a novel, potential antipsychotic, combining potent dopamine d2 receptor antagonism with serotonin reuptake inhibition. Bioorg Med Chem Lett 13 (2003) 405-408
101. Vasquez J., and Baghdoyan H.A. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am J Physiol 280 (2001) R598-R601
102. Vittoz N.M., and Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex. Involvement of the ventral tegmental area. Neuropsychopharmacology 37 (2005) 384-395
103. Wall P.D. Excitability changes in afferent fiber terminaisons and their relation to slow potential. J Physiol Lond 142 (1958) 1-21
104. Wang Z., and McCormick D.A. Control of firing mode of corticotectal and corticopontine layer V burst-generating neurons by norepinephrine, acetylcholine and 1S, 3R-ACPD. J Neurosci 13 (1993) 2199-2216
105. Weinberger D.R., Berman K.F., and Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. 1. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43 (1986) 114-124
106. Werth E., Achermann P., and Borbely A.A. Selective REM sleep deprivation during daytime: II. Muscle atonia in non-REM sleep. Am J Physiol Regul Integr Comp Physiol 283 (2002) 527-532
107. Young C.E., Beach T.G., Falkai P., and Honer W.G. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8 (1998) 261-268